Unilabs Reports Third Quarter 2015 Financial Results
Unilabs, one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services, announced further growth today, reporting that for the quarter ending 30 September 2015, revenue was €152.8m, compared to €141.7m in Q3 2014.  The results show a significant and positive organic sales growth of 4.5% (CER†) leading to EBITDA growth vs Q3 2014 of 12.9%.  This marks the 5th successive quarter of revenue growth, EBITDA growth and cost savings.
Chris Tue – A new General Manager for Unilabs UK
Chris Tue – A new General Manager for Unilabs UK on the 2nd of November. Unilabs has had a strong footprint in the Uk through its two business units, Unilabs IHS and Unilabs York.

Our Partnerships, Expertise & Network

We are a partner of choice and leading provider of outsourced diagnostic services with more than 200 diagnostic contracts across Europe.
Our services include: laboratory medicine, medical imaging, histopathology, reproductive medicine, and drug development services.
With operations in 12 countries, we are positioned as a regional leader with one of the broadest geographic coverage in Europe.